Celcuity, Inc. (CELC)

111.08 +3.92 (+3.66%) USD  |  NASDAQ  |  Jan 22, 15:16
More

Celcuity Net Non-Operating Interest Income Expense (Quarterly)

Net Non-Operating Interest Income Expense (Quarterly) Chart

View Net Non-Operating Interest Income Expense (Quarterly) for CELC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Non-Operating Interest Income Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks
Start Trial
Olema Pharmaceuticals, Inc. Upgrade
Replimune Group, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade